The potential of GHK as an anti-aging peptide
HPLC can support a purity claim, while MS or LC-MS/MS supports identity context
However, large-scale randomized controlled trials in humans are absent, limiting evidence for clinical safety and efficacy claims
Its unfounded and reckless, said Eric Topol, director of the Scripps Research Translational Institute
The strongest evidence remains in topical applications, while injectable GHK-Cu should be viewed as an investigational compound with unknown safety profiles
About Me Let's get to know each other Im Alexandros Manifavas, as a Senior System Administrator with extensive experience in the information technology and services industry, I am well-versed in a variety of technical areas including device management solutions, Azure, Active Directory, MECM, Intune, M365, and PowerShell